the tivic health team is dedicated to exploring the use of microcurrents for therapeutic benefit and pioneering advances in bioelectronic medicine. our initial focus is delivering sinus pain relief. synus is new alternative for temporary relief of sinus pain and pressure. www.tivichealth.com/synus currently, the most recommended treatment for those experiencing recurring sinus pain is daily flushing of the nose with salt water. we believe people should have access to relief without pills, sprays and flushes.
Company profile
Ticker
TIVC
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
SEC CIK
Corporate docs
IRS number
814016391
TIVC stock data
Latest filings (excl ownership)
8-K
Other Events
8 May 24
S-1/A
IPO registration (amended)
8 May 24
S-1/A
IPO registration (amended)
29 Apr 24
S-1
IPO registration
29 Mar 24
8-K
Tivic Reports Fiscal Year 2023 Financial Results
25 Mar 24
10-K
2023 FY
Annual report
25 Mar 24
8-K
Termination of a Material Definitive Agreement
26 Jan 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Tivic Reports Third Quarter 2023 Financial Results
14 Nov 23
8-K
Tivic Health Partners with InStep Health to Access over 2,500 Healthcare
26 Sep 23
Latest ownership filings
4
Kimberly Ann Bambach
22 Mar 24
4
Blake Gurfein
22 Mar 24
4
Jennifer Ernst
22 Mar 24
SC 13G/A
L1 Capital Global Opportunities Master Fund, Ltd.
9 Feb 24
SC 13G/A
Bigger Capital, LLC
1 Feb 24
SC 13G/A
L1 Capital Global Opportunities Master Fund, Ltd.
24 Jul 23
SC 13G
L1 Capital Global Opportunities Master Fund, Ltd.
17 Jul 23
4
Karen Drexler
16 Jun 23
4
Dean Zikria
16 Jun 23
4
Sheryle Bolton
16 Jun 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 5.17 mm | 5.17 mm | 5.17 mm | 5.17 mm | 5.17 mm | 5.17 mm |
Cash burn (monthly) | (no burn) | 96.58 k | 586.67 k | 688.08 k | 623.67 k | 747.00 k |
Cash used (since last report) | n/a | 704.47 k | 4.28 mm | 5.02 mm | 4.55 mm | 5.45 mm |
Cash remaining | n/a | 4.46 mm | 889.88 k | 150.16 k | 620.01 k | -279.58 k |
Runway (months of cash) | n/a | 46.2 | 1.5 | 0.2 | 1.0 | -0.4 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 12 |
Opened positions | 4 |
Closed positions | 4 |
Increased positions | 2 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 94.85 mm |
Total shares | 2.02 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Bigger Capital Fund L P | 1.10 mm | $551.00 k |
Sheets Smith Wealth Management | 600.00 k | $63.84 mm |
Two Sigma Securities | 96.82 k | $10.25 mm |
Boothbay Fund Management | 34.20 k | $3.62 mm |
Millennium Management | 30.19 k | $3.20 mm |
UBS UBS Group AG - Registered Shares | 29.62 k | $3.14 mm |
Susquehanna International | 29.14 k | $3.09 mm |
Cubist Systematic Strategies | 28.59 k | $3.03 mm |
HRT Financial | 26.94 k | $2.00 k |
One68 Global Capital | 19.10 k | $2.02 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Mar 24 | Jennifer Ernst | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.34 | 32,000 | 42.88 k | 32,000 |
12 Mar 24 | Blake Gurfein | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.34 | 10,000 | 13.40 k | 10,000 |
12 Mar 24 | Kimberly Ann Bambach | Common Stock | Grant | Acquire A | No | No | 0 | 7,500 | 0.00 | 7,500 |
14 Jun 23 | Karen Drexler | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.09 | 25,000 | 2.25 k | 25,000 |
14 Jun 23 | Dean Zikria | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.09 | 25,000 | 2.25 k | 25,000 |
News
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
8 May 24
Why Tivic Health Shares Are Up Today
8 May 24
Tivic Health Announces Completion Of Non-Invasive VNS Study Demonstrating Effective Biological Changes In The Autonomic, Cardiac, And Central Nervous Systems
8 May 24
12 Health Care Stocks Moving In Thursday's After-Market Session
25 Apr 24
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
26 Mar 24